Among the sixteen national UK finalists in 2022 demonstrating outstanding business integrity and leadership, Yvanne is the only female business leader working in clinical research to be honoured with this prestigious award.
Yvanne founded the award-winning CRO, PHARMExcel, in 2009 with a mission to provide an accessible, client-first clinical trial management service to support the NHS. Since then, the company has rapidly expanded into the commercial biotech sector managing clinical trials across multiple therapeutic areas throughout the UK and Europe.
Testament to the expertise and solid reputation the business has built up in ground-breaking drug development, PHARMExcel was selected CRO for the world’s first COVID booster vaccine trial (Covboost) and the first into-man safety and performance trial of a new liver dialysis device study-DIALIVE TM .
Commenting on her award Yvanne said: “Thank you for this award. I am truly honoured to receive it. It’s an even greater honour to be working with such a talented team. This award is testimony to the expertise, enthusiasm, and commitment from everyone at PHARMExcel and all our clinical trial partners and colleagues. “
PHARMExcel is an award-winning, full-service Contract Research Organisation (CRO) providing a flexible and innovative approach to clinical trial delivery. The company is recognised for its in-depth knowledge and experience of the clinical research environment, particularly in the UK, and has a network of regulatory and industry associates, allowing it to provide a global reach.
Katie Howe, Head of Marketing
T: +44 (0)20 3642 6654
© Copyright 2023 PHARMexcel | Website by Union 10 Design